scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger

Reuters09-24

scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger

**scPharmaceuticals Inc. Secures $10 Million Loan from MannKind Corporation** Burlington, MA - September 24, 2025 - scPharmaceuticals Inc. has entered into a new financing agreement with MannKind Corporation, securing a $10 million unsecured loan. The arrangement was formalized on September 23, 2025, with scPharmaceuticals issuing a promissory note to MannKind in exchange for the funds. The note carries an interest rate tied to the company's existing credit agreement, with a margin ranging between 4.75% and 5.00%. The new loan comes as part of a broader merger transaction announced in August, under which MannKind plans to acquire scPharmaceuticals through a tender offer. The loan can be prepaid in full at any time before maturity, and includes customary financial covenants and restrictions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. scPharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-214262), on September 24, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2569270140?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-24 20:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569270140","market":"nz","top_or_hot":-1,"title":"scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        **scPharmaceuticals Inc. Secures $10 Million Loan from MannKind Corporation** Burlington, MA - September 24, 2025 - scPharmaceuticals Inc. has entered into a new financing agreement with MannKind Corporation, securing a $10 million unsecured loan. The arrangement was formalized on September 23, 2025, with scPharmaceuticals issuing a promissory note to MannKind in exchange for the funds. The note carries an interest rate tied to the company's existing credit agreement, with a margin ranging between 4.75% and 5.00%. The new loan comes as part of a broader merger transaction announced in August, under which MannKind plans to acquire scPharmaceuticals through a tender offer. The loan can be prepaid in full at any time before maturity, and includes customary financial covenants and restrictions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. scPharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-214262), on September 24, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nscPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-24 20:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        **scPharmaceuticals Inc. Secures $10 Million Loan from MannKind Corporation** Burlington, MA - September 24, 2025 - scPharmaceuticals Inc. has entered into a new financing agreement with MannKind Corporation, securing a $10 million unsecured loan. The arrangement was formalized on September 23, 2025, with scPharmaceuticals issuing a promissory note to MannKind in exchange for the funds. The note carries an interest rate tied to the company's existing credit agreement, with a margin ranging between 4.75% and 5.00%. The new loan comes as part of a broader merger transaction announced in August, under which MannKind plans to acquire scPharmaceuticals through a tender offer. The loan can be prepaid in full at any time before maturity, and includes customary financial covenants and restrictions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. scPharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-214262), on September 24, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nNDL7qVbz3:1","article_id":"2569270140","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569270140","pubTimestamp":1758718004,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"**scPharmaceuticals Inc. Secures $10 Million Loan from MannKind Corporation** Burlington, MA - September 24, 2025 - scPharmaceuticals Inc. has entered into a new financing agreement with MannKind Corporation, securing a $10 million unsecured loan. The arrangement was formalized on September 23, 2025, with scPharmaceuticals issuing a promissory note to MannKind in exchange for the funds. The note carries an interest rate tied to the company's existing credit agreement, with a margin ranging between 4.75% and 5.00%. The new loan comes as part of a broader merger transaction announced in August, under which MannKind plans to acquire scPharmaceuticals through a tender offer. The loan can be prepaid in full at any time before maturity, and includes customary financial covenants and restrictions.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BK4584":"避孕概念","SCPH":"Scpharmaceuticals Inc.","MNKD":"曼恩凯德生物医疗","BK4139":"生物科技"},"translate_title":"scPharmaceuticals在即将进行的合并中从MannKind Corporation获得1000万美元无担保贷款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SCPH":0.9,"MNKD":0.9},"content_text":"scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger\n    \n\n        **scPharmaceuticals Inc. Secures $10 Million Loan from MannKind Corporation** Burlington, MA - September 24, 2025 - scPharmaceuticals Inc. has entered into a new financing agreement with MannKind Corporation, securing a $10 million unsecured loan. The arrangement was formalized on September 23, 2025, with scPharmaceuticals issuing a promissory note to MannKind in exchange for the funds. The note carries an interest rate tied to the company's existing credit agreement, with a margin ranging between 4.75% and 5.00%. The new loan comes as part of a broader merger transaction announced in August, under which MannKind plans to acquire scPharmaceuticals through a tender offer. The loan can be prepaid in full at any time before maturity, and includes customary financial covenants and restrictions.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. scPharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-214262), on September 24, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2569270140","isCrawlerRequest":true}